Meningococcal C vaccination coverage data by age group
Reimbursement data by age group
Due to a change in data sources, the meningococcal C table has been split into two.
Proportion of people vaccinated since January 2010 (source: EGB) | |||||
Age |
24 months |
3–9 years |
10–14 years |
15–19 years |
20–25 years |
As of 12/31/2011 |
48.0% |
29.2% |
14.9% |
8.6% |
1.7% |
As of 12/31/2012 |
54.1% |
36.8% |
20.6% |
13.3% |
2.8% |
As of 12/31/2013 |
56.4% |
46.2% |
24.8% |
17.0% |
4.0% |
As of 12/31/2014 |
64.0% |
53.6% |
28.7% |
20.5% |
5.4% |
Proportion of people vaccinated since 2010 (source: SNDS-DCIR. Processing: Santé publique France) | |||||||
5 months* |
24 months |
2–4 years |
5–9 years |
10–14 years |
15–19 years |
20–24 years |
|
- |
68.2% |
66.1% |
52.3% |
31.4% |
22.5% |
9.4% |
|
As of 12/31/2016 |
- |
70.0% |
68.1% |
58.3% |
34.8% |
25.1% |
12.2% |
As of 12/31/2017 |
35.5% |
72.6% |
72.3% |
65.4% |
39.6% |
28.4% |
15.3% |
As of 12/31/2018 |
75.8% |
78.6% |
75.7% |
70.3% |
45.8% |
31.9% |
18.6% |
| As of 12/31/2019 | 84.9% | 84.5% | 78.2% | 72.9% | 52.9% | 34.8% | 20.7% |
| As of 12/31/2020 | 88.0% | 89.9% | 80.8% | 75.3% | 59.2% | 37.8% | 23.6% |
| As of 12/31/2021 | 88.7% | 91.4% | 83.0% | 77.4% | 64.6% | 40.6% | 26.9% |
| As of 12/31/2022 | 88.8% | 92.7% | 85.0% | 78.5% | 68.9% | 43.8% | 29.1% |
| As of 12/31/2023 | 89.1% | N/A | 90.6% | 79.5% | 71.9% | 48.0% | 31.3% |
* Vaccination coverage at 5 months is calculated among children born between January and March
Data at age 6
Meningococcal C vaccination coverage among children in the final year of preschool (5–6 years old), France (source: Drees-Dgesco, national health surveys of children in the final year of preschool. Processed by Santé publique France) | |
2014–2015 |
|
Meningococcal C |
43.8% (95% CI: 43.1–44.5) |
Antona D, Fonteneau L, Lévy-Bruhl D, Guignon N, De Peretti C et al. Vaccination coverage among children and adolescents in France: results of school-based surveys, 2001–2004. Bull Epidemiol Hebd 2007,6: 45–9.
Fonteneau L, Urcun JM, Guthmann JP, Collet M, Neulat N et al. Vaccination coverage among 6-year-old children in their final year of preschool, France, 2005–2006. Archives de Pédiatrie 2013, 20: 241–7.
Data at age 11
Meningococcal C vaccination coverage among children in the second year of elementary school (CM2) (age 11), France (source: Drees-Dgesco, national health surveys of students in the final year of preschool. Public Health France) | |
2014-2015 |
|
Meningococcal C |
44.4% (95% CI: 42.4–46.3) |
Antona D, Fonteneau L, Lévy-Bruhl D, Guignon N, De Peretti C et al. Vaccination coverage among children and adolescents in France: results of school-based surveys, 2001–2004. Bull Epidemiol Hebd 2007,6: 45–9.
Fonteneau L, Urcun JM, Kerneur C, Guthmann JP, Guignon N et al. Vaccination coverage among 11-year-old children in fifth grade, France, 2004–2005. Bull Epidemiol Hebd 2008,51–52:493–7.
Survey data
Based on data from the 2021 France Public Health Barometer, vaccination coverage against meningococcal C among children aged 11 to 14 in mainland France was estimated at 56.7% [54.3–59.1]; 27.9% [25.9–30.0] of parents reported being certain that their child had been vaccinated, and 28.8% [26.7–31.0] reported that their child was likely vaccinated.
Santé publique France. Public Health Bulletin on Vaccination. National Edition. April 2024, 26p.
